We deliver quality, value driven, bespoke social performance programmes, generating shared impact for leading oil and gas and mining companies, and development agencies.
• Services: project scoping and design, advisory, implementation and evaluations to private, public and NGO sector clients. We are perfectly placed to build synergies and partnerships between all of these client areas.
• Global Cl
ients: Total, BG Group, Hess, CNOOC, BHP Billiton, Rio Tinto, Newcrest, Ok Tedi, Tullow, DFID/UKAid, DFAT/AusAid, the IFC, UN agencies and Malaria Consortium.
• Core principles: (i) client focus and bespoke services, (ii) deep contextual understanding and local solution finding, (iii) technical rigour and quality assurance, (iv) value for money.
• Active in Myanmar since 2012; Montrose Myanmar registered in December 2014; permanent office with three full-time staff in Yangon; access to wide range of national and international consultants through a strong local partnership network; Programmes Director Asia-Pacific based in Yangon.
• Currently evaluating the PSI-implemented Artemisinin Mono-Therapy Replacement (AMTR) project funded by DFID. The AMTR project works with private sector pharmaceutical supply chains and service providers to provide subsidised, quality-assured artemisinin combination therapy to control spread of artemisinin resistant malaria in Myanmar and Greater Mekong. Work includes case studies and working papers available from early 2015:
1. Lessons learnt on private provider incentives to use Rapid Diagnostic Tests (RDTs)
2. Role of the private pharmaceutical sector in containing artemisinin resistance in Myanmar
3. Impact of the AMTR project in containing artemisinin resistance
4. Qualitative study into treatment seeking behaviour of consumers within Myanmar
5. Sensitivity analysis of calculation of Disability Adjusted Life Years (DALYs) in the AMTR project context
6. Options for adding Primaquine to standard P. falciparum malaria treatment guidelines
7. Qualitative analysis of the decision making process amongst migrant populations in south east Myanmar regarding the use of private or public sector health providers
8. Examination of the role of the broader private sector in contributing to the spread or containment of artemisinin resistance in Myanmar
• Supported the Myanmar Ministry of Health (MoH) Department of Medical Research (DMR) to conduct a Service Availability and Readiness Assessment (SARA) of health facilities across Myanmar, under a WHO contract in late 2014. Work included development of survey tools, support to DMR field survey teams, qualitative field research and quantitative data analysis.
